The BC Ministry of Health has officially launched its publicly funded IVF program, making fertility care more accessible for individuals and couples across the province. Starting July 2, eligible residents may receive up to $19,000 in financial support for a single IVF cycle. As Dr. Niamh Tallon, Olive’s Clinical Medical Director, shares: “This is a monumental moment for individuals and couples struggling with infertility... This program is a critical step toward ensuring more equitable access to fertility care.”
In a recent Vancouver Sun article, Dr. Niamh Tallon, co-director at Olive Fertility Centre, discusses the hope and uncertainty surrounding the launch of B.C.’s new IVF funding program. She highlights the growing demand, unanswered questions about access, and the emotional toll on those navigating infertility.
As fertility treatment costs in Canada continue to soar, many Canadians are turning to international options to build their families. Dr. Gary Nakhuda, co-founder of Olive Fertility Centre, weighs in on the systemic gaps that drive hopeful parents abroad—from long waitlists to restrictive donation laws. With insight from his decades of experience, Dr. Nakhuda advocates for more accessible fertility care at home, noting that hundreds of Olive patients each year explore treatment options overseas.
As part of Canadian Fertility Awareness Week, Dr. Niamh Fallon and Dr. Beth Taylor of Olive Fertility Centre joined a CityConnect special to help clear up common misconceptions around fertility. The segment also highlights the personal journeys of two Metro Vancouver women who share their experiences with egg freezing and IVF.
Olive fertility specialist Dr. Niamh Tallon, who consulted on the BC IVF program, joins CityNews to break down how the three-month delay is impacting their patients, and how the initiative will help those on the path to parenthood.
Dr. Areiyu Zhang of Olive Fertility Centre shares insights on the three-month delay of BC’s publicly funded IVF program. She highlights the uncertainty patients face as they await details on how funding will be managed and allocated. With many eager families struggling with the timing, some have chosen to move forward with treatment rather than wait. Read more about Dr. Zhang’s perspective in CBC’s latest article.